The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds i... The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the funds investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified. Show more
Q&A on Splits and Reverse Splits ProShares, a premier provider of ETFs, announced today forward and reverse share splits on eleven of its ETFs. The splits will not change the total value of...
Six new ETFs offer leveraged and inverse exposure to key industry sectors ProShares, a premier provider of alternative ETFs, today announced the launch of six new geared ETFs. The new...
Reverse Share Splits of Ten ETFs ProShares, a premier provider of alternative ETFs, announced today reverse share splits on ten of its ETFs. The reverse splits will not change the value...
NEW YORK, June 10, 2013 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced changes to the methodology of the NASDAQ Biotechnology Index® (Nasdaq:NBI). The NASDAQ...
ProShares, the nation’s fourth most successful exchange traded fund (ETF) company,1 announced today the launch of ProShares UltraPro Short 20+ Year Treasury (NYSE: TTT). The ETF...
ProShares, a premier provider of alternative exchange traded funds (ETFs), today announced the launch of ProShares Ultra DJ-UBS Natural Gas (NYSE: BOIL) and ProShares UltraShort...
ProShares®, a premier provider of alternative exchange traded funds (ETFs), today announced the launch of the ProShares Hedge Replication ETF (NYSE: HDG). HDG’s benchmark is...
ProShares, a premier provider of alternative exchange traded funds (ETFs), today announced the launch of the first ETFs that provide magnified exposure to the high yield and...
NEW YORK, April 19, 2010 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the first quarter and year-to-date activities report for the NASDAQ OMX Global Index Group...
NEW YORK, April 8, 2010 (GLOBE NEWSWIRE) -- The NASDAQ Stock Market® (Nasdaq:NDAQ) began trading today two new exchange-traded funds (ETFs) designed to provide leveraged and inverse exposure to...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.25 | -7.32708089097 | 17.06 | 17.06 | 15.8 | 11535 | 16.36714563 | SP |
4 | 0.07 | 0.444726810673 | 15.74 | 18.01 | 14.1 | 15035 | 16.2821863 | SP |
12 | 0.58 | 3.80827314511 | 15.23 | 18.01 | 14.05 | 13816 | 15.38051465 | SP |
26 | -2.66 | -14.4017325393 | 18.47 | 18.77 | 14.05 | 11578 | 15.36297389 | SP |
52 | -8.28 | -34.3711083437 | 24.09 | 24.09 | 14.05 | 13091 | 16.7411187 | SP |
156 | -3.18 | -16.7456556082 | 18.99 | 35.64 | 14.05 | 15506 | 21.9472447 | SP |
260 | 2.02 | 14.6482958666 | 13.79 | 36.49 | 6.9501 | 50577 | 16.10719822 | SP |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales